2
Clinical Trials associated with Diagnostic Patch for Allergic Contact Dermatitis 01(Zhejiang Wolwo Bio-Pharmaceutical)一项在中国变应性接触性皮炎患者中探索皮炎诊断贴剂01贴诊断效果及安全性的临床研究—多中心、多剂量、开放的II期临床试验
[Translation] A clinical study to explore the diagnostic efficacy and safety of the dermatitis diagnostic patch 01 in Chinese patients with allergic contact dermatitis—a multicenter, multi-dose, open-label phase II clinical trial
通过一项多中心、开放的Ⅱ期临床试验,考察三种不同剂量皮炎诊断贴剂01贴在变应性接触性皮炎患者中的诊断效果及安全性,并为后续Ⅲ期临床试验的开展探索最佳剂量。
[Translation] Through a multicenter, open Phase II clinical trial, the diagnostic efficacy and safety of three different doses of Dermatitis Diagnostic Patch 01 in patients with allergic contact dermatitis were investigated, and the optimal dose was explored for the subsequent Phase III clinical trial.
一项在中国健康志愿者中探索皮炎诊断贴剂01贴耐受性的临床研究
[Translation] A clinical study to explore the tolerance of dermatitis diagnostic patch 01 in healthy Chinese volunteers
评价四种不同剂量的皮炎诊断贴剂01贴在健康志愿者中单次给药的耐受性。
[Translation] To evaluate the tolerability of a single administration of four different doses of Dermatitis Diagnostic Patch 01 in healthy volunteers.
100 Clinical Results associated with Diagnostic Patch for Allergic Contact Dermatitis 01(Zhejiang Wolwo Bio-Pharmaceutical)
100 Translational Medicine associated with Diagnostic Patch for Allergic Contact Dermatitis 01(Zhejiang Wolwo Bio-Pharmaceutical)
100 Patents (Medical) associated with Diagnostic Patch for Allergic Contact Dermatitis 01(Zhejiang Wolwo Bio-Pharmaceutical)
100 Deals associated with Diagnostic Patch for Allergic Contact Dermatitis 01(Zhejiang Wolwo Bio-Pharmaceutical)